INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
CA
Clements Carol AnnChief Digital & Tech Officer
JBLUJETBLUE AIRWAYS CORP
Open-market sale · 10b5-1 plan
SELL$9,420
2,000 sh
Aug 31, 2026
Page 412 of 1689
← PrevNext →
Sep 2, 2026
traded Aug 31, 2026
+2d
SEC Form 4

Evidence

5
DS
Dhaliwal Harpreet S.Chief Technical Ops Officer
PCVXVaxcyte, Inc.
Tax withholding
F$41K
659 sh
Sep 2, 2026Sep 2, 2026
traded Sep 2, 2026
+0dSEC Form 4

Evidence

5
OM
Okeke Angelique MEVP, General Counsel
FFIVF5, INC.
Grant or award
A—
3,002 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

5
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Grant or award
A$2,489
41 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

5
FJ
Flores JessicaExecutive VP & CAO
SBRASabra Health Care REIT, Inc.
Grant or award
A—
382 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

5
AK
Akgonul Rifat KerimChief Product Officer
PEGAPEGASYSTEMS INC
Tax withholding
F$21K
569 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

5
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M$558K
44.3K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

5
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Tax withholding
F$3,914
16 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

5
MS
Mehta SamirPresident and CEO
LHXL3HARRIS TECHNOLOGIES, INC. /DE/
Grant or award
A—
11.8K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

5
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Gift
G—
261.9K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

5
HM
Holt MichaelChief Financial Officer
MORNMorningstar, Inc.
Tax withholding
F$12K
54 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

5
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Grant or award
A$3,217
53 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

5
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Gift
G—
261.9K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

5
DS
Dhaliwal Harpreet S.Chief Technical Ops Officer
PCVXVaxcyte, Inc.
Tax withholding
F$22K
361 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

5
AK
Akgonul Rifat KerimChief Product Officer
PEGAPEGASYSTEMS INC
Option exercise
M—
1,176 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

4
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M—
11.0K sh
Sep 2, 2026Sep 2, 2026
traded Sep 2, 2026
+0dSEC Form 4

Evidence

3
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M—
13.5K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

2
SP
Stewart Frank P.SVP, Advanced Cellular
QRVOQorvo, Inc.
Gift · 10b5-1 plan
G—
1,874 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

2
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Tax withholding
F$15K
243 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

2
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Tax withholding
F$20K
326 sh
Sep 2, 2026Sep 2, 2026
traded Sep 2, 2026
+0dSEC Form 4

Evidence

2
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Option exercise · 10b5-1 plan
M$70K
50.0K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

2
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M$617K
49.0K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

2
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$8,205
100 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

1
SC
Sumner CrystalSee Remarks
MQMarqeta, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
1,250 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

0
BJ
Balance Austin JChief Product Officer
GRNDGrindr Inc.
Option exercise · 10b5-1 plan
M$110K
26.3K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

0
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M$139K
11.0K sh
Sep 2, 2026Sep 2, 2026
traded Sep 2, 2026
+0dSEC Form 4

Evidence

0
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M—
49.0K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

0
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Derivative conversion · 10b5-1 plan
C—
5,939 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

0
HN
Hathi NeeshaMD, Head Wealth Adv, Bnk, Tst
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M—
3,177 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

0
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M$110K
13.5K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

0
BJ
Balance Austin JChief Product Officer
GRNDGrindr Inc.
Option exercise · 10b5-1 plan
M—
26.3K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

0
LL
Linnenbringer Jeanne L.Chief Operations Officer
CNOCNO Financial Group, Inc.
Option exercise · 10b5-1 plan
M—
5,010 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

0
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Derivative conversion · 10b5-1 plan
C—
17.8K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

0
HN
Hathi NeeshaMD, Head Wealth Adv, Bnk, Tst
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M$165K
3,177 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

0
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Grant or award · 10b5-1 plan
A—
21.7K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

0
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
17.8K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

0
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Option exercise · 10b5-1 plan
M—
50.0K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

0
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Option exercise · 10b5-1 plan
M$6,058
17.8K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

0
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M—
9,271 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

49
ED
Ericson Brady DDirector, President and CEO
PHINPHINIA INC.
Open-market sale
SELL$1.84M
26.9K sh
Aug 31, 2026Sep 1, 2026
traded Aug 31, 2026
+1dSEC Form 4

Evidence